Is Ischemic Stroke Declines During the COVID-19 Pandemic?

dc.authoridŞahin, Erkan Melih/0000-0003-1520-8464
dc.authoridTORAMAN, Cetin/0000-0001-5319-0731
dc.contributor.authorOcak, Ozgul
dc.contributor.authorŞahin, Erkan Melih
dc.contributor.authorToraman, Cetin
dc.date.accessioned2025-01-27T20:25:03Z
dc.date.available2025-01-27T20:25:03Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: A decrease in the number of ischemic strokes has been reported during the coronavirus disease-2019 (COVID-19) pandemic period. The aim of this study was to determine the effect of COVID-19 and associated risk factors on the number of ischemic strokes in hospitalizations during the COVID-19 period. Methods: This cross-sectional study was conducted using hospital records. Data of patients who underwent a COVID-19 real -time reversetranscriptase polymerase chain reaction (RT-PCR) test between 2020 and 2021 were included. In addition to RT-PCR test results, the diagnosis of ischemic stroke and known risk factors for ischemic stroke (gender, age, diabetes mellitus, chronic obstructive pulmonary disease, hypertension, hypercholesterolemia, congestive heart failure, coronary artery disease, peripheral vascular disease, chronic kidney disease) were evaluated. Results: According to the inclusion criteria, 25,522 patient records were included in the analysis. There were 123 (0.6%) acute ischemic stroke patients among 19,051 COVID-19-negative patients and 23 (0.4%) among 6471 positive patients. Among the covariates, age and diabetes have a significant effect on acute ischemic stroke. In path analysis, the negative direct effect of RT-PCR positivity on acute ischemic stroke was reversed through the mediator variable effect of diabetes and age. Patients with diabetes and higher age have an increased risk of acute ischemic stroke if they have COVID-19. Conclusion: Evidence is not satisfactory to determine the effect of COVID-19 on ischemic stroke. Reports of a decrease in the number of hospitalizations due to ischemic stroke are accumulating. This result may be due to the direct effect of COVID-19, the lack of recognition of clinical symptoms, or the decrease in hospital admissions of patients without a severe clinical picture. In the presence of accompanying risk factors such as age and diabetes that will aggravate the stroke clinic, the reducing effect of COVID-19 on the number of ischemic strokes disappears.
dc.identifier.doi10.4274/BMJ.galenos.2023.2022.11-1
dc.identifier.endpage41
dc.identifier.issn1305-9319
dc.identifier.issn1305-9327
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85190324309
dc.identifier.scopusqualityQ4
dc.identifier.startpage35
dc.identifier.trdizinid1239764
dc.identifier.urihttps://doi.org/10.4274/BMJ.galenos.2023.2022.11-1
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1239764
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22421
dc.identifier.volume20
dc.identifier.wosWOS:001194773000008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofMedical Journal of Bakirkoy
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectCOVID-19
dc.subjectischemic stroke
dc.subjectCOVID-19 testing
dc.subjectdiagnosis
dc.subjectepidemiology
dc.subjectpandemic
dc.titleIs Ischemic Stroke Declines During the COVID-19 Pandemic?
dc.title.alternativeCOVİD-19 Pandemisinde İskemik İnmeler Azaldı mı?
dc.typeArticle

Dosyalar